– The CRL requests a quality process change Junshi Biosciences and Coherus believe is readily addressable – – BLA resubmission anticipated by mid-summer 2022 with expected six month FDA review timeline – – Onsite inspections in China, impeded to date by COVID-19-related travel restrictions, are required for FDA’s completion of BLA review – – Toripalimab will be the first and […]
Fourth acquisition brings traffic signal priority solution to the Miovision platform ST. PAUL, Minn., April 17, 2023 (GLOBE NEWSWIRE) — Miovision, whose scalable intelligent transportation solutions help cities reduce traffic congestion while improving safety, has acquired Global Traffic Technologies (GTT). GTT, whose Opticom product line is a market-leading emergency pre-emption and traffic signal priority solution, […]